Price:
Rs. 39,000.00
Sample Type: Tissue
Fasting Not Required
Booking Procedure:
- Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You can make the payment to the technician at the time of collection
- Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
- Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.
Frequently Asked Questions (FAQ's):
What does the NextGen GeneCore Somatic 161 Gene Panel at Metropolis Healthcare include?
It analyzes 161 cancer-related genes for mutations, fusions, and copy number changes to guide precision oncology.
How does Metropolis Healthcare perform this comprehensive genomic panel?
Metropolis Healthcare uses high-coverage NGS with advanced bioinformatics pipelines to ensure accurate tumor profiling.
Who should consider taking this test at Metropolis Healthcare?
Patients diagnosed with solid tumors who need detailed molecular insights for targeted or immunotherapy decisions should consider this panel.
Is fasting required for this genomic test at Metropolis Healthcare?
No fasting is needed; the test uses tumor tissue and/or blood as advised by the clinician.
How long do results take at Metropolis Healthcare?
Results usually take 2–3 weeks due to the extensive sequencing and detailed variant analysis.
Can this test at Metropolis Healthcare help identify targeted therapy options?
Yes, it detects actionable mutations linked to FDA-approved and investigational targeted therapies.
How accurate is the NGS testing performed by Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy using deep coverage, robust QC metrics, and validated sequencing workflows.
Does this panel assist with long-term cancer management at Metropolis Healthcare?
Yes, the comprehensive molecular data supports personalized treatment planning, prognosis evaluation, and therapy monitoring.